Although a few studies have identified correlations between Chi3L1 and insulin resistance, dyslipidemia, and acute infections, much remains unknown about the mechanism of Chi3L1 in inflammation and metabolic homeostasis [41–43], particularly in the setting of HIV/AIDS. Here, CHI3L1 is linked to Insulin resistance.